Moderna - Phase 3 Trial of Mrna-1283, an Investigational Next-Generation Covid-19 Vaccine, Has Met Its Primary Efficacy Endpoint
Moderna的MRNA-1283下一代冠狀病毒疫苗的第三階段試驗已經達到了其主要有效性終點
Moderna - Phase 3 Trial of Mrna-1283, an Investigational Next-Generation Covid-19 Vaccine, Has Met Its Primary Efficacy Endpoint
Moderna的MRNA-1283下一代冠狀病毒疫苗的第三階段試驗已經達到了其主要有效性終點
譯文內容由第三人軟體翻譯。